FDA
-
-
-
-
-
-
-
Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals
-
-
-
-
-
-
-
Ex-FDA chief Gottlieb sees investment opportunity in 'unloved' antibiotics
-
-
-
-
-
-
-
Tetraphase Pharma (TTPH) Says New Studies Highlight Activity of XERAVA Against Gram-Negative and Gram-Positive Clinical Isolates
-
-
-
-
-
-
-
Tetraphase Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Corporate Developments
-
-
-
-
-
-
-
Tetraphase Pharmaceuticals to Present at BMO Prescriptions for Success Healthcare Conference
-
-
-
-
-
-
-
Tetraphase Pharma (TTPH) Reports Positive Data from Post-Hoc Analysis of Phase 3 Trials Showing Efficacy of XERAVA (eravacycline) in Obese & Renally Impaired Patients
-
-
-
-
-
-
-
Tetraphase Pharmaceuticals Announces Commercial Launch of XERAVA™ in the United States
-
322,220 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

